Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

Radicioni, G., Ceppe, A., Ford, A. A., Alexis, N. E., Barr, R. G., Bleecker, E. R., Christenson, S. A., Cooper, C. B., Han, M. K., Hansel, N. N., Hastie, A. T., Hoffman, E. A., Kanner, R. E., Martinez, F. J., Ozkan, E., Paine, R., Woodruff, P. G., O’Neal, W. K., Boucher, R. C., & Kesimer, M. (2021). Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. The Lancet Respiratory Medicine, 9(11), 1241–1254. https://doi.org/10.1016/s2213-2600(21)00079-5
Authors:
Giorgia Radicioni
Agathe Ceppe
Amina A Ford
Neil E Alexis
R Graham Barr
Eugene R Bleecker
Stephanie A Christenson
Christopher B Cooper
MeiLan K Han
Nadia N Hansel
Annette T Hastie
Eric A Hoffman
Richard E Kanner
Fernando J Martinez
Esin Ozkan
Robert Paine
Prescott G Woodruff
Wanda K O'Neal
Richard C Boucher
Mehmet Kesimer
Affiliated Authors:
R Graham Barr
Publication Type:
Article
Unique ID:
10.1016/S2213-2600(21)00079-5
PMID:
Publication Date:
Data Source:
Scopus

Record Created: